Septerna (SEPN) Change in Receivables (2023 - 2026)
Septerna (SEPN) posted quarterly Change in Receivables of $486000.0 for Q1 2026, up 515.19% year-over-year from $79000.0 in Q1 2025, and down 71.6% quarter-over-quarter from $1.7 million in Q4 2025.
Septerna (SEPN) Change in Receivables (2023 - 2026) Analysis & Trends
Septerna's Change in Receivables history runs 4 years deep, the most recent figure standing at $486000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 515.19% year-over-year to $486000.0; the TTM figure through Mar 2026 stood at $10.6 million (up 7612.06% YoY), while the FY2025 annual figure was $10.2 million, up 50825.0% from the prior year.
- Change in Receivables for Q1 2026 stood at $486000.0, down from $1.7 million in the prior quarter.
- The five-year high for Change in Receivables was $8.5 million in Q3 2025, with the low at -$190000.0 in Q2 2024.
- The 4-year median for Change in Receivables is $98500.0 (2023), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables sank 133.9% in 2024, then jumped 84840.0% in 2025.
- Septerna's Change in Receivables stood at $118000.0 in 2023, then tumbled by 133.9% to -$40000.0 in 2024, then surged by 4377.5% to $1.7 million in 2025, then plunged by 71.6% to $486000.0 in 2026.
- Business Quant data shows SEPN's Change in Receivables at $486000.0 in Q1 2026, $1.7 million in Q4 2025, and $8.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Septerna | 2.08 Bn | 2.08 Bn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Jun 30, 2026 | 1.32 Mn |
| Mar 31, 2026 | 486,000.00 |
| Mar 31, 2026 | 486,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | -99,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Mar 31, 2024 | 240,000.00 |